This Stock-Split Stock Is Up 30% Since Splitting Its Shares
DexCom has been doing better than big tech stocks that have had more notable stock splits this year.
Mindfully Curated
DexCom has been doing better than big tech stocks that have had more notable stock splits this year.
The entertainment giant is making too much money at Disney World and Disneyland to bring back its full slate of annual passes.
The entertainment giant is making too much money at Disney World and Disneyland to bring back its full slate of annual passes.
RXT earnings call for the period ending June 30, 2022.
On this episode of FYI, we showcase our latest episode of In The Know, a monthly video series on which our CEO and CIO Cathie Wood discusses fiscal policy, monetary policy, market signals, economic indicators, and innovation.
TSMC continues to see strong revenue growth despite a bleak outlook from numerous semiconductor companies.
It’s difficult to see anything stopping Apple at this point.
Has this former hypergrowth gaming stock finally bottomed out?
Investors slammed on the brakes after Carvana’s share price soared during the pandemic. Here’s how it can get back on track.
Disney wasn’t the only company to break its record, and it points toward an important trend.
NASA’s Fermi Gamma-ray Space Telescope confirms one supernova remnant as a launch site for some of our galaxy’s highest-energy protons.
A handful of companies are in businesses that defy the impact of economic weakness.
Fortinet is a leader in defending against growing cybersecurity threats.
Investing in these first-rate stocks is likely to reward patient shareholders over the years, especially when starting from today’s low share prices.
A 401(k) may seem like a perfect retirement account, but you may want to look at other options.
The company is coming out of the pandemic stronger than ever.
The number of young people globally who can’t find a job this year is set to reach 73 million – that’s a full six million more than before COVID-19 – the UN labour agency said on Thursday.
Deep pockets aren’t a requirement for winning big in the stock market.
EGIO earnings call for the period ending June 30, 2022.
A drug typically used to treat enlarged prostates and high blood pressure has shown promise as a potential new therapy for motor neuron disease (MND) — also known as amyotrophic lateral sclerosis (ALS) — according to a new study.